Cargando…

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy

The treatment of rheumatoid arthritis (RA) has been transformed with the introduction of biologic disease modifying anti-rheumatic drugs (bDMARD) and more recently, targeted synthetic DMARD (tsDMARD) therapies in the form of janus-kinase inhibitors. Nevertheless, response to these agents varies such...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ouboussad, Lylia, Burska, Agata N., Melville, Andrew, Buch, Maya H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433846/ https://www.ncbi.nlm.nih.gov/pubmed/30941350 http://dx.doi.org/10.3389/fmed.2019.00045

Ejemplares similares

Cytokines as Biomarkers in Rheumatoid Arthritis
por: Burska, Agata, et al.
Publicado: (2014)

Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis
por: Smith, Melanie H., et al.
Publicado: (2023)

TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes()
por: Savic, Sinisa, et al.
Publicado: (2014)

Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis
por: Plein, Sven, et al.
Publicado: (2020)

Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
por: Humby, Frances, et al.
Publicado: (2019)

Single-centre experience of refractory rheumatoid arthritis
por: Fitton, John, et al.
Publicado: (2022)

Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations
por: Horton, Sarah, et al.
Publicado: (2010)

Cell biology of synovial inflammation and secondary osteoporosis in rheumatoid arthritis
por: Tanaka, Y, et al.
Publicado: (2003)

Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis
por: Pap, Thomas, et al.
Publicado: (2000)

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
por: Dennis, Glynn, et al.
Publicado: (2014)

Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis
por: Ouboussad, L., et al.
Publicado: (2017)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis
por: Penatti, Alessandra, et al.
Publicado: (2017)

Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Burska, Agata N., et al.
Publicado: (2015)

Synovial Histopathology in Early Rheumatoid Arthritis
por: Hirohata, Shunsei, et al.
Publicado: (2000)

Activation of Synovial Fibroblasts in Rheumatoid Arthritis
por: Gay, Steffen, et al.
Publicado: (2000)

Synovial fluid proteome in rheumatoid arthritis
por: Bhattacharjee, Mitali, et al.
Publicado: (2016)

A NF-κB-Dependent Dual Promoter-Enhancer Initiates the Lipopolysaccharide-Mediated Transcriptional Activation of the Chicken Lysozyme in Macrophages
por: Witham, James, et al.
Publicado: (2013)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Stratified medicine in rheumatoid arthritis—the MATURA programme
por: Barton, Anne, et al.
Publicado: (2017)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
por: Findeisen, Kate E, et al.
Publicado: (2021)

Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study
por: Bissell, Lesley-Anne, et al.
Publicado: (2018)

Fibroblast biology: Synovial fibroblasts in rheumatoid arthritis - leading role or chorus line?
por: Kontoyiannis, Dimitris, et al.
Publicado: (2000)

New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology
por: Sandhu, Gurvisha, et al.
Publicado: (2022)

Heterochromatin protein 1 gamma and IκB kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages
por: Thorne, James L., et al.
Publicado: (2012)

Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
por: Furer, Victoria, et al.
Publicado: (2023)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts
por: Müller-Ladner, Ulf, et al.
Publicado: (2007)

Comparison of the nodule and synovial lesions of rheumatoid arthritis
por: Highton, J, et al.
Publicado: (2003)

Evidence for synovial fibroblasts spreading rheumatoid arthritis
por: Müller-Ladner, Ulf, et al.
Publicado: (2012)

Synovial Tissue Response to Treatment in Rheumatoid Arthritis
por: Vieira-Sousa, Elsa, et al.
Publicado: (2011)

Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
por: Tsuchiya, Haruka, et al.
Publicado: (2021)

Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
por: Ferrari, Mathieu, et al.
Publicado: (2021)

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
por: Gaujoux-Viala, Cécile, et al.
Publicado: (2014)

Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2021)

Heterogeneity of Synovial Molecular Patterns in Patients with Arthritis
por: Lauwerys, Bernard R., et al.
Publicado: (2015)

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
por: Romão, Vasco C., et al.
Publicado: (2017)

Identification of key candidate genes and biological pathways in the synovial tissue of patients with rheumatoid arthritis
por: Yu, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3s2kffu4mk2kn9skr6kin2849a